Dapagliflozin prevents kidney podocytes pyroptosis via miR-155-5p/HO-1/ NLRP3 axis modulation

被引:16
作者
Zhang, Zhen-Wang [1 ,2 ]
Tang, Ming-Qiu [3 ]
Liu, Wu [1 ,2 ]
Song, Yi [3 ]
Gao, Man-Jun [3 ]
Ni, Ping [4 ]
Zhang, Dan-Dan [1 ,2 ]
Mo, Qi-gui [1 ,2 ]
Zhao, Bao-Qing [1 ,2 ]
机构
[1] Hubei Univ Sci & Technol, Med Res Inst, Xianning 437000, Peoples R China
[2] Hubei Univ Sci & Technol, Hubei Key Lab Diabet & Angiopathy, Xianning 437000, Peoples R China
[3] Hubei Univ Sci & Technol, Sch Pharm, Xianning 437000, Peoples R China
[4] Hubei Univ Sci & Technol, Clin Med, Xianning 437000, Peoples R China
关键词
Diabetes mellitus; Pyroptosis; Dapagliflozin; miR-155-5p; HO-1; CELL-DEATH; INFLAMMASOME; DISEASE; ACTIVATION; CASPASES;
D O I
10.1016/j.intimp.2024.111785
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Diabetic nephropathy (DN) is a significant clinical microvascular complication associated with diabetes mellitus (DM), and end -stage diabetes giving rise to kidney failure is developing into the major etiological factor of chronic kidney failure. Dapagliflozin is reported to limit podocyte damage in DM, which has proven to protect against renal failure. Mounting evidence has demonstrated that pyroptosis is associated with DM progression. Nevertheless, whether pyroptosis causes DN and the underlying molecular pathways remain obscure. In this study, we aimed to explore the antipyroptotic attributes of dapagliflozin and elucidate the underlying mechanisms of kidney damage in diabetes. In vivo, experiments were conducted in streptozotocin (STZ)-induced type 2 diabetic mice, which were administered dapagliflozin via gavage for 6 weeks. Subsequently, the specific organizational characteristics and expression of pyroptosis-related genes were evaluated. Intragastric dapagliflozin administration markedly reduced renal tissue injury. Meanwhile, dapagliflozin also attenuated the expression level of pyroptosis associated genes, including ASC, cleaved Caspase-1, GSDMD N -termini, NLRP3, IL -18, and IL1 beta in renal tissue of dapagliflozin-treated animals. Similar antipyroptotic effects were observed in palmitic acid (PA) -treated mouse podocytes. We also found that heme oxygenase 1 (HO -1) enhanced the protection of mouse podocyte clone 5 cells (MPC5). Moreover, miR-155-5p inhibition increased pyroptosis in PA -treated MPC5 cells, suggesting that miR-155-5p acts as an endogenous stimulator that increases HO -1 expression and reduces pyroptosis. Hence, our findings imply that dapagliflozin inhibits podocyte pyroptosis via the miR-155-5p/HO-1/ NLRP3 axis in DM. Furthermore, dapagliflozin substitution may be regarded as an effective strategy for preventing pyroptosis in the kidney, including a therapeutic option for treating pyroptosis-related DN.
引用
收藏
页数:13
相关论文
共 69 条
[1]   Pyroptosis in diabetic nephropathy [J].
Al Mamun, Abdullah ;
Mimi, Anjuman Ara ;
Wu, Yanqing ;
Zaeem, Muhammad ;
Aziz, Md. Abdul ;
Suchi, Suzia Aktar ;
Alyafeai, Eman ;
Munir, Fahad ;
Xiao, Jian .
CLINICA CHIMICA ACTA, 2021, 523 :131-143
[2]   Activation of autophagy and suppression of apoptosis by dapagliflozin attenuates experimental inflammatory bowel disease in rats: Targeting AMPK/mTOR, HMGB1/RAGE and Nrf2/HO-1 pathways [J].
Arab, Hany H. ;
Al-Shorbagy, Muhammad Y. ;
Saad, Muhammed A. .
CHEMICO-BIOLOGICAL INTERACTIONS, 2021, 335
[3]   Global trend analysis of diabetes mellitus incidence, mortality, and mortality-to-incidence ratio from 1990 to 2019 [J].
Balooch Hasankhani, Mohammadreza ;
Mirzaei, Hossein ;
Karamoozian, Ali .
SCIENTIFIC REPORTS, 2023, 13 (01)
[4]   miR-155 in cancer drug resistance and as target for miRNA-based therapeutics [J].
Bayraktar, Recep ;
Van Roosbroeck, Katrien .
CANCER AND METASTASIS REVIEWS, 2018, 37 (01) :33-44
[5]   Ticagrelor and Dapagliflozin Have Additive Effects in Ameliorating Diabetic Nephropathy in Mice with Type-2 Diabetes Mellitus [J].
Birnbaum, Yochai ;
Chen, Huan ;
Tran, Dat ;
Nylander, Sven ;
Ye, Yumei .
CARDIOVASCULAR DRUGS AND THERAPY, 2022, 36 (05) :829-840
[6]   Combined SGLT2 and DPP4 Inhibition Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Nephropathy in Mice with Type 2 Diabetes [J].
Birnbaum, Yochai ;
Bajaj, Mandeep ;
Yang, Hsiu-Chiung ;
Ye, Yumei .
CARDIOVASCULAR DRUGS AND THERAPY, 2018, 32 (02) :135-145
[7]  
Bloomgarden Zachary T, 2005, Diabetes Care, V28, P745, DOI 10.2337/diacare.28.3.745
[8]   SGLT2 inhibitor dapagliflozin limits podocyte damage in proteinuric nondiabetic nephropathy [J].
Cassis, Paola ;
Locatelli, Monica ;
Cerullo, Domenico ;
Corna, Daniela ;
Buelli, Simona ;
Zanchi, Cristina ;
Villa, Sebastian ;
Morigi, Marina ;
Remuzzi, Giuseppe ;
Benigni, Ariela ;
Zoja, Carlamaria .
JCI INSIGHT, 2018, 3 (15)
[9]   Network analysis identifies circulating miR-155 as predictive biomarker of type 2 diabetes mellitus development in obese patients: a pilot study [J].
Catanzaro, Giuseppina ;
Conte, Federica ;
Trocchianesi, Sofia ;
Splendiani, Elena ;
Bimonte, Viviana Maria ;
Mocini, Edoardo ;
Filardi, Tiziana ;
Po, Agnese ;
Besharat, Zein Mersini ;
Gentile, Maria Cristina ;
Paci, Paola ;
Morano, Susanna ;
Migliaccio, Silvia ;
Ferretti, Elisabetta .
SCIENTIFIC REPORTS, 2023, 13 (01)
[10]   Disulfide-bond A oxidoreductase-like protein protects against ectopic fat deposition and lipid-related kidney damage in diabetic nephropathy [J].
Chen, Xianghui ;
Han, Yachun ;
Gao, Peng ;
Yang, Ming ;
Xiao, Li ;
Xiong, Xiaofen ;
Zhao, Hao ;
Tang, Chengyuan ;
Chen, Guochun ;
Zhu, Xuejing ;
Yuan, Shuguang ;
Liu, Fuyou ;
Dong, Lily Q. ;
Liu, Feng ;
Kanwar, Yashpal S. ;
Sun, Lin .
KIDNEY INTERNATIONAL, 2019, 95 (04) :880-895